Dura makes $79 million offer for Spiros

DURA offered to acquire its R&D vehicle, SDCO, for $12.50 a share. If DURA buys SDCO, it plans to discontinue the Albuterol Spiros program to treat asthma but will continue with Beclomethasone Spiros ...